4YD-12817-78844
4 vaccinations
3 coded responses
50 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 357 / AL
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-07-14
- 2021-10-13
-
2021-10-20
Dose 3 — Pfizer-BioNTech
-
2021-10-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-10-22
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-11-03
-
2021-11-11
Survey response — day 21, dose 3MedDRA: Dizziness postural — Feeling: GoodFree text: Dizziness when ging from lying to sitting. Im not taking new medication.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Survey response — day 28, dose 3MedDRA: Vertigo positional — Feeling: GoodFree text: Still have vertigo when going from prone to sitting or sitting to prone.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-24
- 2021-12-01
- 2022-01-19
- 2022-04-20
-
2022-04-27
Dose 4 — Pfizer-BioNTech
- 2022-04-27
- 2022-04-28
- 2022-04-29
- 2022-04-30
- 2022-05-01
- 2022-05-02
- 2022-05-03
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-06-01
- 2022-06-08
-
2022-07-27
Survey response — 3 months, dose 4MedDRA: Endometrial thickening, Uterine dilation and curettage, Uterine polypectomy — Feeling: GoodFree text: Thick uterine lining. Had hystroscopy and D&C with polyps sent to pathology.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-26
- 2023-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-10-20 | Pfizer-BioNTech | No |
| 4 | 2022-04-27 | Pfizer-BioNTech | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Dizziness when ging from lying to sitting. Im not taking new medication.
Release 10 — day 28, dose 3
Symptoms: Still have vertigo when going from prone to sitting or sitting to prone.
Release 12 — 3 months, dose 4
Symptoms: Thick uterine lining. Had hystroscopy and D&C with polyps sent to pathology.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness postural | · | · | ✓ |
| SD | Endometrial thickening | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SD | Uterine polypectomy | · | · | ✓ |
| SD | Vertigo positional | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release